Evidence map›Paper›PMID 36159970›Full record

ArticleFrontiers in genetics2022

Novel heterozygous mutation in

Ran Du, Jishi Liu, Yiqiao Hu, Song Peng, Liangliang Fan, Rong Xiang, Hao Huang

Abstract read
In one paragraph

Article in Frontiers in genetics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. The same heterozygousFrontiers in genetics · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ran DuDepartment of Nephrology, The Third Xiangya Hospital Central South University, Changsha, China.
Jishi LiuDepartment of Nephrology, The Third Xiangya Hospital Central South University, Changsha, China.
Yiqiao HuDepartment of Cell Biology, Hunan Key Laboratory of Animal Models for Human Diseases, School of Life Sciences, Central South University, Changsha, China.
Song PengDepartment of Radiology, The Third Xiangya Hospital Central South University, Changsha, China.
Liangliang FanDepartment of Nephrology, The Third Xiangya Hospital Central South University, Changsha, China.
Rong XiangDepartment of Nephrology, The Third Xiangya Hospital Central South University, Changsha, China.
Hao HuangDepartment of Nephrology, The Third Xiangya Hospital Central South University, Changsha, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Alport syndromechronic kidney diseaseCOL4A4mutationwhole-exome sequencing

Identifiers

PMID36159970
PMCPMC9501878

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.